Alessandro Concas

Prof. Alessandro Concas

University of Cagliari, Cagliari, Sardegna, Italy
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2006 in Chemosphere
Verified
Journal Article
Closed access
Alessandro ConcasAlessandro Concas
Alessandro Concas
CAC. Ardau
C. Ardau
ACA. Cristini
A. Cristini
PZP. Zuddas
P. Zuddas
GCGiacomo Cao
Giacomo Cao

28 April 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
GFGiacomo Fais
Giacomo Fais
AMAlessia Manca
Alessia Manca
FBFederico Bolognesi
Federico Bolognesi
MBMassimiliano Borselli
Massimiliano Borselli
Alessandro ConcasAlessandro Concas
Alessandro Concas
Giuseppe GiannaccareGiuseppe Giannaccare
Giuseppe Giannaccare
Spirulina is the most studied cyanobacterium species for both pharmacological applications and the food industry. The aim of the present review is to summarize the potential benefits of the use of Spirulina for improving healthcare both in space and on Earth. Regarding the first field of application, Spirulina could represent a new technology for the sustainment of long-duration manned missions to planets beyond the Lower Earth Orbit (e.g., Mars); furthermore, it could help astronauts stay healthy while exposed to a variety of stress factors that can have negative consequences even after years. As far as the second field of application, Spirulina could have an active role in various aspects of medicine, such as metabolism, oncology, ophthalmology, central and peripheral nervous systems, and nephrology. The recent findings of the capacity of Spirulina to improve stem cells mobility and to increase immune response have opened new intriguing scenarios in oncological and infectious diseases, respectively.

1 July 2014 in Bioresource Technology
Verified
Journal Article
Closed access
ASAlberto Steriti
Alberto Steriti
RRRoberto Rossi
Roberto Rossi
Alessandro ConcasAlessandro Concas
Alessandro Concas
GCGiacomo Cao
Giacomo Cao

7 June 2023 in Marine Drugs
Verified
Journal Article
Open access
PDF file
ASAgnieszka Sidorowicz
Agnieszka Sidorowicz
GFGiacomo Fais
Giacomo Fais
MCMattia Casula
Mattia Casula
MBMassimiliano Borselli
Massimiliano Borselli
Giuseppe GiannaccareGiuseppe Giannaccare
Giuseppe Giannaccare
Alessandro ConcasAlessandro Concas
Alessandro Concas
Over the years, microalgae have been a source of useful compounds mainly used as food and dietary supplements. Recently, microalgae have been used as a source of metabolites that can participate in the synthesis of several nanoparticles through inexpensive and environmentally friendly routes alternative to chemical synthesis. Notably, the occurrence of global health threats focused attention on the microalgae application in the medicinal field. In this review, we report the influence of secondary metabolites from marine and freshwater microalgae and cyanobacteria on the synthesis of nanoparticles that were applied as therapeutics. In addition, the use of isolated compounds on the surface of nanoparticles to combat diseases has also been addressed. Although studies have proven the beneficial effect of high-value bioproducts on microalgae and their potential in medicine, there is still room for understanding their exact role in the human body and translating lab-based research into clinical trials.

1 December 2012 in Chemical Engineering Journal
Verified
Journal Article
Closed access
Alessandro ConcasAlessandro Concas
Alessandro Concas
GLGiovanni Antonio Lutzu
Giovanni Antonio Lutzu
MPMassimo Pisu
Massimo Pisu
GCGiacomo Cao
Giacomo Cao

1 September 2009 in Powder Technology
Verified
Journal Article
Closed access
SFS. Fadda
S. Fadda
ACAlberto Cincotti
Alberto Cincotti
Alessandro ConcasAlessandro Concas
Alessandro Concas
MPM. Pisu
M. Pisu
GCGiacomo Cao
Giacomo Cao